| Report Title | Price | Action |
|---|---|---|
| Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021
Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 Summary Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 375
|
$ 2500 | |
| Hormone-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021
Hormone-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Hormone-Sensitive Prostate Cancer (Oncology) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
| Cells Expressing Latent Membrane Protein 1 (Protein p63 or LMP1) - Drugs in Development, 2021
Cells Expressing Latent Membrane Protein 1 (Protein p63 or LMP1) - Drugs in Development, 2021 Summary Cells Expressing Latent Membrane Protein 1 (Pr...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Epidermal Growth Factor Receptor (Proto Oncogene c ErbB 1 or Receptor Tyrosine Protein Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) - Drugs in Development, 2021
Epidermal Growth Factor Receptor (Proto Oncogene c ErbB 1 or Receptor Tyrosine Protein Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) - Drugs ...
Published: Apr-2021 | No. of Pages: 325
|
$ 3500 | |
| Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021
Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021 Summary Mesothelin (CAK1 Antigen or Pre ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) - Drugs in Development, 2021
Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) - Drugs in Development, 2021 Summary Low Affin...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Post-Transplant Lymphoproliferative Disorder (Oncology) - Drugs in Development, 2021
Post-Transplant Lymphoproliferative Disorder (Oncology) - Drugs in Development, 2021 Summary Post-Transplant Lymphoproliferative Disorder (Oncology)...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Familial Amyloid Cardiomyopathy (Metabolic Disorders) - Drugs in Development, 2021
Familial Amyloid Cardiomyopathy (Metabolic Disorders) - Drugs in Development, 2021 Summary Familial Amyloid Cardiomyopathy (Metabolic Disorders) - D...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Renal Failure (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021
Renal Failure (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 Summary Renal Failure (Genito Urinary System And Sex Hormones) -...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Human Papillomavirus Infections (Infectious Disease) - Drugs in Development, 2021
Human Papillomavirus Infections (Infectious Disease) - Drugs in Development, 2021 Summary Human Papillomavirus Infections (Infectious Disease) - Dru...
Published: Apr-2021 | No. of Pages: 115
|
$ 2000 | |
| Cells Expressing Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or p145 c Kit or CD117 or KIT or EC 2.7.10.1) - Drugs in Development, 2021
Cells Expressing Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarc...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) - Drugs in Development, 2021
Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) - Drugs in Development, 2021 Summary Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 375
|
$ 3500 | |
| Na+/K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) - Drugs in Development, 2021
Na+/K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) - Drugs in Development, 2021 Summary Na+/K+ Exchanging AT...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Drugs in Development, 2021
Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Drugs ...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Urinary Tract Cancer (Oncology) - Drugs in Development, 2021
Urinary Tract Cancer (Oncology) - Drugs in Development, 2021 Summary Urinary Tract Cancer (Oncology) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) (Musculoskeletal Disorders) - Drugs in Development, 2021
Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) (Musculoskeletal Disorders) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Respiratory Depression (Hypoventilation) (Respiratory) - Drugs in Development, 2021
Respiratory Depression (Hypoventilation) (Respiratory) - Drugs in Development, 2021 Summary Respiratory Depression (Hypoventilation) (Respiratory) -...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Hyperlipidemia (Metabolic Disorders) - Drugs in Development, 2021
Hyperlipidemia (Metabolic Disorders) - Drugs in Development, 2021 Summary Hyperlipidemia (Metabolic Disorders) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 120
|
$ 2000 | |
| Cells Expressing Melanoma Antigen Preferentially Expressed In Tumors (Cancer/Testis Antigen 130 or Opa Interacting Protein 4 or OIP4 or Preferentially Expressed Antigen Of Melanoma or PRAME) - Drugs in Development, 2021
Cells Expressing Melanoma Antigen Preferentially Expressed In Tumors (Cancer/Testis Antigen 130 or Opa Interacting Protein 4 or OIP4 or Preferentially...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) - Drugs in Development, 2021
Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) - Drugs in Development, 2021 Summary Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 375
|
$ 3500 |